Scarica l'app Stockscreener
0.00
100.00%
-5.84
Precedente Chiudi:
$5.84
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$189.98M
Reddito:
$425.17M
Utile/perdita netta:
$-92.21M
Rapporto P/E:
0.00
EPS:
-2.57
Flusso di cassa netto:
$-67.42M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$10.37
Nevro Corp Stock (NVRO) Company Profile
Nome
Nevro Corp
Settore
Industria
Telefono
650-251-0005
Indirizzo
1800 BRIDGE PARKWAY, REDWOOD CITY, CA
Confronta NVRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NVRO
Nevro Corp
|
0.00 | 189.98M | 425.17M | -92.21M | -67.42M | -2.57 |
|
ABT
Abbott Laboratories
|
132.82 | 232.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
101.60 | 148.00B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
373.63 | 146.09B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.39 | 112.11B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.32 | 44.79B | 5.54B | 4.18B | 623.10M | 7.00 |
Nevro Corp Stock (NVRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-10 | Aggiornamento | Jefferies | Underperform → Hold |
| 2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-03 | Iniziato | Wells Fargo | Equal Weight |
| 2024-12-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-08-09 | Aggiornamento | Citigroup | Sell → Neutral |
| 2024-08-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2024-08-07 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Downgrade | JP Morgan | Neutral → Underweight |
| 2024-08-07 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-05-22 | Downgrade | Citigroup | Neutral → Sell |
| 2024-02-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-01-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-12-21 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-05-31 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-05-15 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-04-14 | Iniziato | Mizuho | Neutral |
| 2023-01-17 | Downgrade | Citigroup | Buy → Neutral |
| 2023-01-06 | Downgrade | Piper Sandler | Neutral → Underweight |
| 2022-12-20 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-12-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-05 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-04-13 | Ripresa | Truist | Hold |
| 2022-04-06 | Iniziato | Wolfe Research | Underperform |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-11-09 | Downgrade | Truist | Buy → Hold |
| 2021-08-05 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2021-08-05 | Downgrade | Citigroup | Buy → Neutral |
| 2021-08-05 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-08-05 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-07-09 | Downgrade | Redburn | Buy → Neutral |
| 2021-07-06 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-02-02 | Iniziato | Piper Sandler | Overweight |
| 2020-10-23 | Iniziato | Guggenheim | Buy |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-06-08 | Aggiornamento | UBS | Sell → Neutral |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-26 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-06 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-11-07 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2019-10-22 | Iniziato | Oppenheimer | Perform |
| 2019-03-20 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-20 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2018-11-28 | Iniziato | UBS | Sell |
| 2018-11-07 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-11-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-11-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-19 | Downgrade | Goldman | Neutral → Sell |
| 2018-07-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-05-08 | Reiterato | Canaccord Genuity | Buy |
| 2018-05-08 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2018-05-08 | Downgrade | Wells Fargo | Outperform → Market Perform |
Mostra tutto
Nevro Corp Borsa (NVRO) Ultime notizie
Collegeville Office Buildings Sell to Globus Medical with Staggering Price Cut - DELCO.Today
Zimmer hires former Nevro CEO Kevin Thornal - Yahoo Finance
Zimmer Biomet Taps Growth Expert Kevin Thornal to Lead Global Business Strategy and Americas Operations - Stock Titan
BTIG Downgrades Globus Medical to Neutral From Buy - marketscreener.com
JMP maintains Market Perform on Globus Medical stock By Investing.com - Investing.com India
JMP maintains Market Perform on Globus Medical stock - Investing.com Australia
Price T Rowe Associates Inc. MD Acquires 38,869 Shares of Nevro Corp. (NYSE:NVRO) - Defense World
Globus Medical, Inc. (NYSE:GMED) Q1 2025 Earnings Call Transcript - Insider Monkey
Globus Medical stock target cut to $78 by Oppenheimer - Investing.com Nigeria
Truist cuts Globus Medical stock target to $68, maintains hold By Investing.com - Investing.com Nigeria
Globus Medical’s Strategic Acquisition of Nevro Corp: A Catalyst for Growth and Market Expansion - TipRanks
Nevro to Present at Wells Fargo 2024 Healthcare Conference - Quantisnow
Press Release Distribution & PR Platform - ACCESS Newswire
Globus Medical: Digesting Another Acquisition (NYSE:GMED) - Seeking Alpha
Learn to Evaluate (NVRO) using the Charts - news.stocktradersdaily.com
Nevro Corp. Data Breach under Investigation by Levi & Korsinsky, LLP - Louisiana First News
Nevro Receives CE Mark for Senza II™ Spinal Cord Stimulation System Delivering HF10™ Therapy | Libero Quotidiano.it - Libero Quotidiano
Globus Medical Announces Q1 Earnings Date: Leading Musculoskeletal Tech Firm Reports May 8 - Stock Titan
Nevro (NYSE:NVRO) Earns Hold Rating from Analysts at StockNews.com - Defense World
Levi & Korsinsky, LLP Investigates Nevro Corp. Data Breach - ACCESS Newswire
Form S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments - ADVFN
Prudential Financial Inc. Grows Position in Nevro Corp. (NYSE:NVRO) - MarketBeat
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of Nevro Corp. Data Breach - ACCESS Newswire
Spinal Cord Stimulator Market to Set Phenomenal Growth From 2025 to 2034 | Medtronic,Boston Scientific,Nevro Corp - openPR.com
GMED Stock May Benefit Following the Acquisition of Nevro - MSN
Raymond James Financial Inc. Invests $287,000 in Nevro Corp. (NYSE:NVRO) - Defense World
Nevro (NYSE:NVRO) Coverage Initiated at StockNews.com - MarketBeat
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating - GlobeNewswire
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Nevro Corp. Customers Whose Data May Have Been Compromised - TradingView
(NVRO) Trading Report - news.stocktradersdaily.com
Nevro Files Notice of Data Breach Affecting Confidential Consumer Information - JD Supra
Globus acquires US medical device company Nevro - Yahoo Finance
Globus Medical Completes Acquisition of Nevro Corp. - MyChesCo
Nevro Corp. Investigated by Federman & Sherwood for Data Breach - GlobeNewswire
Nevro to Participate in Wells Fargo 2022 MedTech R&D Spotlight Call Series - MarketScreener
Nevro Data Breach Investigation - Claim Depot
Nevro Corp Completes Merger and Delists from NYSE - TipRanks
Why Is Nevro (NVRO) Up 0.9% Since Last Earnings Report? - Yahoo Finance
Nevro Corp completes merger with Globus Medical - Investing.com Australia
Nevro Corp. Data Breach Exposes SSNs & Health Information - Claim Depot
Globus Medical Closes Acquisition of Nevro - MarketScreener
Globus Medical Acquires Nevro Corp. - citybiz
Globus Medical completes acquisition of Nevro - MassDevice
Globus Medical completes acquisition of Nevro Corp. - grafa.com
Nevro Corp completes merger with Globus Medical By Investing.com - Investing.com South Africa
SEC Form POS AM filed by Nevro Corp. - Quantisnow
Nevro Corp Azioni (NVRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):